Inhibikase Therapeutics Inc (IKT) Stock: Exploring a Year of Highs, Lows, and Trading Volume
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Inhibikase Therapeutics Inc’s current trading price is -51.49% away from its 52-week high, while its distance from the 52-week low is 244.30%. The stock’s price range over this period has fluctuated between $0.79 and $5.61. The company, operating within the financial sector, had a trading volume of approximately 1.08 million for the day, which was noticeably higher than the average daily share volume of 0.15 million over the last 3 months. Inhibikase Therapeutics Inc experienced a somewhat